Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.49
-0.1300-1.12%
Post-market: 11.490.00000.00%17:10 EDT
Volume:1.48M
Turnover:17.04M
Market Cap:875.95M
PE:-4.10
High:11.88
Open:11.73
Low:11.22
Close:11.62
Loading ...

Nurix Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
09 Apr

Nurix Therapeutics Inc : Needham Cuts Target Price to $27 From $28

THOMSON REUTERS
·
09 Apr

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
09 Apr

Nurix Therapeutics Q1 Net Loss Narrows, Revenue Increases

MT Newswires Live
·
09 Apr

Nurix Therapeutics Inc reports results for the quarter ended February 28 - Earnings Summary

Reuters
·
09 Apr

Nurix Therapeutics Q1 EPS $(0.67) Beats $(0.78) Estimate, Sales $18.45M Beat $12.71M Estimate

Benzinga
·
09 Apr

Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
09 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Apr

Leerink Partners Sticks to Its Hold Rating for Nurix Therapeutics (NRIX)

TIPRANKS
·
04 Apr

NRIX Stock Up as SNY In-Licenses Rights to Autoimmune Diseases Program

Zacks
·
03 Apr

Truist Financial Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)

TIPRANKS
·
03 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Apr

Nurix Therapeutics, Inc. (NRIX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks
·
02 Apr

Nurix Therapeutics Price Target Maintained With a $36.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Apr

BRIEF-Nurix Licenses A Drug Discovery Program To Sanofi Targeting A Novel Transcription Factor For Autoimmune Diseases

Reuters
·
02 Apr

Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program

MT Newswires Live
·
02 Apr

Nurix Therapeutics in Expanded Collaboration with Sanofi

Dow Jones
·
02 Apr

Nurix Therapeutics- Receives $15 Mln License Extension Fee From Sanofi

THOMSON REUTERS
·
02 Apr

Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases

THOMSON REUTERS
·
02 Apr

Nurix Therapeutics- Eligible for Additional $465 Mln in Milestones and Royalties

THOMSON REUTERS
·
02 Apr